Overview of mouse models of Parkinson's disease

Current Protocols in Mouse Biology
Wojciech BobelaBernard L Schneider

Abstract

Parkinson's disease is a neurodegenerative disorder characterized by the loss of neurons in specific regions of the nervous system, notably in the substantia nigra pars compacta and, in most cases, by the deposition of intraneuronal inclusions named Lewy bodies. These pathological alterations have profound effects on the brain function, leading to the progressive development of various symptoms, the most prominent being the impaired initiation of voluntary movements caused by the loss of dopamine signaling in the basal ganglia. Here, we provide an overview of the mouse models of Parkinson's disease, with the goal of guiding selection of the most appropriate model for studying the question at hand. Pharmacological approaches targeting dopamine signaling and toxins leading to selective degeneration of nigral neurons are used to validate symptomatic treatments that aim at restoring effective dopaminergic function for motor control. Alternative mouse models are based on genetic modifications that are meant to reproduce the inherited alterations associated with familial forms of Parkinson's disease. Although genetic models have most often failed to induce overt degeneration of nigral dopaminergic neurons, they provide essential tool...Continue Reading

References

Dec 1, 1968·European Journal of Pharmacology·U Ungerstedt
Jun 1, 1995·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·B S JeonR E Burke
Aug 28, 1997·Nature·M G SpillantiniM Goedert
Nov 15, 2001·The Journal of Biological Chemistry·Amy B Manning-BogDonato A Di Monte
Oct 9, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Luana L SkaliszRoberto Andreatini
Oct 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·William DauerRene Hen
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Feb 1, 2003·Journal of Neurochemistry·Günter U HöglingerEtienne C Hirsch
Mar 19, 2003·Journal of Neurochemistry·Alison L McCormack, Donato A Di Monte
Aug 14, 2003·Human Molecular Genetics·Jean-Michel ItierJusto Garcia de Yebenes
Aug 22, 2003·The Journal of Biological Chemistry·Matthew S GoldbergJie Shen
Jul 6, 2004·Annals of Neurology·Kevin St P McNaughtC Warren Olanow
Jul 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Rainer Von CoellnTed M Dawson
Feb 18, 2005·Proceedings of the National Academy of Sciences of the United States of America·Francesco FornaiThomas C Südhof
Nov 5, 2005·Cell·Sreeganga ChandraThomas C Südhof
Apr 14, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·George K TofarisMaria Grazia Spillantini
Jul 5, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yufeng YangBingwei Lu
Jul 25, 2006·Annals of Neurology·Amy B Manning-BoğDonato A Di Monte
Jul 25, 2006·Annals of Neurology·Jordi BovéSerge Przedborski
Oct 5, 2006·Journal of Neural Transmission. Supplementum·G U HöglingerE C Hirsch
Jan 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mats I EkstrandNils-Göran Larsson
Jun 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Tohru KitadaJie Shen
Nov 26, 2008·The Journal of Cell Biology·Derek NarendraRichard J Youle
Apr 23, 2009·Neurobiology of Disease·Jason R CannonJ Timothy Greenamyre
Jul 15, 2009·Neurobiology of Disease·Robert E DroletJ Timothy Greenamyre
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Youren TongJie Shen
Aug 22, 2009·Journal of Neurochemistry·Tohru KitadaJie Shen
Dec 18, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Eva Andres-MateosValina L Dawson
Feb 5, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Xianting LiZhenyu Yue

❮ Previous
Next ❯

Citations

Sep 10, 2014·Nature Biotechnology·Marcus MunafòRobi Blumenstein
Mar 3, 2015·Environmental Microbiology·Joseph A Christie-OlezaDavid J Scanlan
Oct 7, 2020·Annual Review of Cell and Developmental Biology·Andrew T Moehlman, Richard J Youle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Related Papers

Current Pharmaceutical Design
Massimiliano Di FilippoPaolo Calabresi
Antioxidants & Redox Signaling
Terina N Martinez, J T Greenamyre
NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics
Sheila M FlemingMarie-Françoise Chesselet
Current Drug Targets. CNS and Neurological Disorders
S M CardosoC R Oliveira
© 2022 Meta ULC. All rights reserved